Andrea L. Merz

473 total citations
14 papers, 381 citations indexed

About

Andrea L. Merz is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Andrea L. Merz has authored 14 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Andrea L. Merz's work include Cancer, Hypoxia, and Metabolism (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Andrea L. Merz is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Andrea L. Merz collaborates with scholars based in United States, Denmark and Germany. Andrea L. Merz's co-authors include Daniel L. Gustafson, Michael E. Long, Natalie J. Serkova, David Raben, Erica L. Bradshaw‐Pierce, J. Muminović, Albrecht E. Melchinger, Thomas Lübberstedt, Joseph A. Zirrolli and Barbara Frederick and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Andrea L. Merz

14 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea L. Merz United States	11	195	115	62	52	47	14	381
Kamila Balušíková Czechia	14	187 1.0×	104 0.9×	62 1.0×	37 0.7×	35 0.7×	20	462
Perry Dhaliwal India	2	251 1.3×	99 0.9×	66 1.1×	30 0.6×	52 1.1×	3	393
Kenji Hyoudou Japan	14	262 1.3×	88 0.8×	112 1.8×	50 1.0×	29 0.6×	15	491
Tobias Hahn United States	13	277 1.4×	161 1.4×	70 1.1×	25 0.5×	68 1.4×	20	510
Bentham Science Publisher SiddikUzzaman India	11	281 1.4×	83 0.7×	65 1.0×	27 0.5×	24 0.5×	18	467
Changshan Yang China	13	362 1.9×	164 1.4×	54 0.9×	68 1.3×	80 1.7×	14	546
Xiong‐Zhi Wu China	12	190 1.0×	109 0.9×	134 2.2×	27 0.5×	48 1.0×	15	452
Joana Márquez Spain	13	174 0.9×	115 1.0×	83 1.3×	23 0.4×	35 0.7×	26	373
Mutsa Madondo Australia	9	211 1.1×	220 1.9×	61 1.0×	20 0.4×	25 0.5×	11	686
Jennifer L. Allensworth United States	7	281 1.4×	132 1.1×	82 1.3×	28 0.5×	50 1.1×	7	493

Countries citing papers authored by Andrea L. Merz

Since Specialization

Citations

This map shows the geographic impact of Andrea L. Merz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea L. Merz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea L. Merz more than expected).

Fields of papers citing papers by Andrea L. Merz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea L. Merz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea L. Merz. The network helps show where Andrea L. Merz may publish in the future.

Co-authorship network of co-authors of Andrea L. Merz

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea L. Merz. A scholar is included among the top collaborators of Andrea L. Merz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea L. Merz. Andrea L. Merz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Rudolph, Michael C., Elizabeth A. Wellberg, Andrew Lewis, et al.. (2014). Thyroid hormone responsive protein Spot14 enhances catalysis of fatty acid synthase in lactating mammary epithelium. Journal of Lipid Research. 55(6). 1052–1065. 30 indexed citations

Dodd, Rebecca D., Andrea L. Merz, Anjelika Dechkovskaia, et al.. (2013). Induction of the Unfolded Protein Response Drives Enhanced Metabolism and Chemoresistance in Glioma Cells. PLoS ONE. 8(8). e73267–e73267. 55 indexed citations

Bradshaw‐Pierce, Erica L., Todd M. Pitts, Gillian N. Kulikowski, et al.. (2013). Utilization of Quantitative In Vivo Pharmacology Approaches to Assess Combination Effects of Everolimus and Irinotecan in Mouse Xenograft Models of Colorectal Cancer. PLoS ONE. 8(3). e58089–e58089. 26 indexed citations

Henry, Curtis J., Andriy Marusyk, Vadym Zaberezhnyy, et al.. (2012). Aging-associated alterations in IL-7 receptor signaling and inflammation promote declining B-lymphopoiesis and increased leukemogenesis (109.9). The Journal of Immunology. 188(1_Supplement). 109.9–109.9. 1 indexed citations

Henry, Curtis J., Andriy Marusyk, Vadym Zaberezhnyy, et al.. (2012). Abstract 4982: Aging-associated alterations in IL-7 receptor signaling and inflammation promote declining B-lymphopoiesis and increased leukemogenesis. Cancer Research. 72(8_Supplement). 4982–4982. 1 indexed citations

Merz, Andrea L. & Natalie J. Serkova. (2009). Use of Nuclear Magnetic Resonance-Based Metabolomics in Detecting Drug Resistance in Cancer. Biomarkers in Medicine. 3(3). 289–306. 23 indexed citations

Gustafson, Daniel L., Barbara Frederick, Andrea L. Merz, & David Raben. (2007). Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima®) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenografts. Cancer Chemotherapy and Pharmacology. 61(2). 179–188. 33 indexed citations

Troiani, Teresa, Natalie J. Serkova, Daniel L. Gustafson, et al.. (2007). Investigation of Two Dosing Schedules of Vandetanib (ZD6474), an Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor Signaling, in Combination with Irinotecan in a Human Colon Cancer Xenograft Model. Clinical Cancer Research. 13(21). 6450–6458. 33 indexed citations

Gustafson, Daniel L., Erica L. Bradshaw‐Pierce, Andrea L. Merz, & Joseph A. Zirrolli. (2006). Tissue Distribution and Metabolism of the Tyrosine Kinase Inhibitor ZD6474 (Zactima) in Tumor-Bearing Nude Mice following Oral Dosing. Journal of Pharmacology and Experimental Therapeutics. 318(2). 872–880. 26 indexed citations

10.

Gustafson, Daniel L., et al.. (2005). P450 induction alters paclitaxel pharmacokinetics and tissue distribution with multiple dosing. Cancer Chemotherapy and Pharmacology. 56(3). 248–254. 28 indexed citations

11.

Muminović, J., Andrea L. Merz, Albrecht E. Melchinger, & Thomas Lübberstedt. (2005). Genetic Structure and Diversity among Radish Varieties as Inferred from AFLP and ISSR Analyses. Journal of the American Society for Horticultural Science. 130(1). 79–87. 30 indexed citations

12.

Gustafson, Daniel L., Andrea L. Merz, & Michael E. Long. (2004). Pharmacokinetics of combined doxorubicin and paclitaxel in mice. Cancer Letters. 220(2). 161–169. 70 indexed citations

13.

Merz, Andrea L., et al.. (2004). 142 Impact of scheduling on combined ZD6474 and radiotherapy in head and neck tumor xenografts. European Journal of Cancer Supplements. 2(8). 45–46. 7 indexed citations

14.

Gustafson, Daniel L., David Siegel, Jeffrey C. Rastatter, et al.. (2003). Kinetics of NAD(P)H:Quinone Oxidoreductase I (NQO1) Inhibition by Mitomycin C in Vitro and in Vivo. Journal of Pharmacology and Experimental Therapeutics. 305(3). 1079–1086. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact